Novo Nordisk Donnelly Award scholarship winners namedJuly 7, 2009 - World TeamTennis (WTT)
Randall Haylock, 18, of Lindenhurst, Ill., and Jillian Tallarico, 21, of Lancaster, Pa., will also receive regional finalist scholarship awards of $2,500.
The Novo Nordisk Donnelly Awards annually award $15,000 in scholarships including two one-time $5,000 scholarships given to two young people, ages 12-21, who have diabetes and play tennis competitively in tournaments or on their school team.
The scholarship program was established by King, through WTT Charities, in 1998 to encourage children with diabetes to lead an active life and compete in tennis. The Novo Nordisk Donnelly Awards are named after two long-time World TeamTennis executives and tennis champions, Diane Donnelly Stone and Tracey Donnelly Maltby, who are sisters. Stone was an All-American and NCAA doubles champion at Northwestern University, and Maltby earned All-Big Ten honors at the University of Iowa. Both women have lived successfully with diabetes since childhood. For more information, visit www.WTT.com.
Novo Nordisk, a world leader in diabetes care, has been the title sponsor of the award since 2002. The company is also partnering with Billie Jean King on Be the Face of Change, a traveling photo exhibit of more than 44 people living with diabetes. For more information, visit www.bethefaceofchange.com.
2009 Novo Nordisk Donnelly Award National Winners:
Kayla Cyr (20), Westminster, Md. - - National Novo Nordisk Donnelly Award recipient ($5,000) Cyr, who was diagnosed at age 14, has played tennis for Penn State York since 2007. The team's cumulative record over the past three years is 53-11 and Cyr led the squad to an 11-1 record in 2009 while playing No. 1 singles and doubles. In 2007, she and her doubles partner took first place in the Penn State University Athletic Conference. In 2008, she took second place in singles in the Conference. Cyr was named to the All Conference team in 2007 and 2008. She also played soccer for 12 years as a child and throughout high school. Cyr is majoring in Psychology with plans for a career in forensic psychology. She will be attending Penn State University (main campus) in the fall.
Heather Welch (20), Columbia, S.C. - National Novo Nordisk Donnelly Award recipient Welch attends the University of South Carolina where she is Vice President of the club tennis team. Welch's team took 29th place at the 64-team USTA National Campus Championships in 2009 and also placed third in the Southern Sectional Championships. In high school, Welch played No. 2 during her junior and senior years, and was awarded MVP honors both years. Welch, who was diagnosed with diabetes at age 12, is majoring in Exercise Science with an emphasis in Scientific Foundations and plans to have a career as a Physician's Assistant in Endocrinology. She is currently on the Dean's List and plans to graduate in 2011.
2009 Novo Nordisk Donnelly Award Regional Winners:
Randall Haylock (18), Lindenhurst, Ill. - Regional Novo Nordisk Donnelly Award recipient ($2,500) Haylock, who was diagnosed at age 13, played four years on his high school tennis team at Lakes Community High School. In his senior year, he played No. 1 doubles with a record of 12-0. In 2008, his team finished in third place at the Sectionals. Haylock graduated from high school this spring and will attend Iowa State University in the fall. He plans to work toward a Bachelor of Science degree in Biological Systems Engineering.
Jillian Tallarico (21), Lancaster, Pa. - Regional Novo Nordisk Donnelly Award recipient ($2,500) Tallarico played No. 1 singles and doubles for King's College in Wilkes-Barre, Pa. As team captain, her individual career record was 21-19 and her team record was 15-7. In 2007, Tallarico took third place in the MAC Conference Championships and her team finished in second place in the Freedom Conference Championships. She was also named to the All Conference team in 2007. Tallarico is scheduled to graduate in 2011 and plans to pursue a career as a Physician's Assistant.
About Novo Nordisk:
Novo Nordisk is a healthcare company with an 86-year history of innovation and achievement in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition to diabetes care, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to economic success, environmental soundness, and social responsibility to employees and customers. With headquarters in Denmark, Novo Nordisk employs more than 27,000 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For global information, visit novonordisk.com; for United States information, visit www.novonordisk- us.com. For information about Novo Nordisk insulin products, visit www.novonordiskcare.com.
World TeamTennis Stories from July 7, 2009
The opinions expressed in this release are those of the organization issuing it, and do not necessarily reflect the thoughts or opinions of OurSports Central or its staff.